Breast Radiotherapy after Lumpectomy — No Longer Always Necessary
Breast-conserving surgery followed by radiotherapy is the standard of care for women with small breast cancers who wish to avoid mastectomy. This approach achieves good local control, does not disturb the women's body image or impair survival, 1 and has been an important step forward in the man...
Gespeichert in:
Veröffentlicht in: | The New England journal of medicine 2004-09, Vol.351 (10), p.1021-1023 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1023 |
---|---|
container_issue | 10 |
container_start_page | 1021 |
container_title | The New England journal of medicine |
container_volume | 351 |
creator | Smith, Ian E Ross, Gillian M |
description | Breast-conserving surgery followed by radiotherapy is the standard of care for women with small breast cancers who wish to avoid mastectomy. This approach achieves good local control, does not disturb the women's body image or impair survival,
1
and has been an important step forward in the management of this disease.
Several trials have compared breast-conserving surgery plus postoperative radiotherapy with breast-conserving surgery alone, and all have shown an increased risk of local recurrence if radiotherapy is omitted but no difference in survival. One of the largest of these trials, the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-06 study, . . . |
doi_str_mv | 10.1056/NEJMe048173 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66839595</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66839595</sourcerecordid><originalsourceid>FETCH-LOGICAL-c379t-81899f39b440d32e61832a8838ce61d9fab735c3674630bbc2616c8a615b2ee83</originalsourceid><addsrcrecordid>eNpt0F1LwzAUBuAgipvTK--lKHgj1aSnTZPLOeYXc4LodUnTU93ol0mL9M4f4S_0l5ixgSLmJoE8vJzzEnLI6DmjEb-YT-_ukYaCxbBFhiwC8MOQ8m0ypDQQfhhLGJA9a5fUHRbKXTJwKAwEY0MyuTSobOs9qmxRt69oVNN7Km_ReLOubFC3ddl7Xx-f3rz2ZnX14j7GxbvqrTdHjdYq0--TnVwVFg8294g8X02fJjf-7OH6djKe-Rpi2fqCCSlzkKmbLoMAORMQKCFAaPfOZK7SGCINPA450DTVAWdcC8VZlAaIAkbkdJ3bmPqtQ9sm5cJqLApVYd3ZhHMBMpKRg8d_4LLuTOVmS4IAJEAYr9DZGmlTW2swTxqzKN06CaPJqtjkV7FOH20iu7TE7MdumnTgZA3K0iYVLst_Y74B9jd8dA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223933475</pqid></control><display><type>article</type><title>Breast Radiotherapy after Lumpectomy — No Longer Always Necessary</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>ProQuest Central UK/Ireland</source><source>New England Journal of Medicine</source><creator>Smith, Ian E ; Ross, Gillian M</creator><creatorcontrib>Smith, Ian E ; Ross, Gillian M</creatorcontrib><description>Breast-conserving surgery followed by radiotherapy is the standard of care for women with small breast cancers who wish to avoid mastectomy. This approach achieves good local control, does not disturb the women's body image or impair survival,
1
and has been an important step forward in the management of this disease.
Several trials have compared breast-conserving surgery plus postoperative radiotherapy with breast-conserving surgery alone, and all have shown an increased risk of local recurrence if radiotherapy is omitted but no difference in survival. One of the largest of these trials, the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-06 study, . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMe048173</identifier><identifier>PMID: 15342811</identifier><identifier>CODEN: NEJMAG</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Age Factors ; Aged ; Antineoplastic Agents, Hormonal - therapeutic use ; Breast cancer ; Breast Neoplasms - radiotherapy ; Breast Neoplasms - therapy ; Combined Modality Therapy ; Female ; Humans ; Mastectomy ; Mastectomy, Segmental ; Middle Aged ; Neoplasm Recurrence, Local ; Neoplasms, Hormone-Dependent - therapy ; Tamoxifen - therapeutic use ; Therapy ; Tumors</subject><ispartof>The New England journal of medicine, 2004-09, Vol.351 (10), p.1021-1023</ispartof><rights>Copyright © 2004 Massachusetts Medical Society. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c379t-81899f39b440d32e61832a8838ce61d9fab735c3674630bbc2616c8a615b2ee83</citedby><cites>FETCH-LOGICAL-c379t-81899f39b440d32e61832a8838ce61d9fab735c3674630bbc2616c8a615b2ee83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMe048173$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/223933475?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>315,781,785,2760,2761,26108,27929,27930,52387,54069,64390,64392,64394,72474</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15342811$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Smith, Ian E</creatorcontrib><creatorcontrib>Ross, Gillian M</creatorcontrib><title>Breast Radiotherapy after Lumpectomy — No Longer Always Necessary</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>Breast-conserving surgery followed by radiotherapy is the standard of care for women with small breast cancers who wish to avoid mastectomy. This approach achieves good local control, does not disturb the women's body image or impair survival,
1
and has been an important step forward in the management of this disease.
Several trials have compared breast-conserving surgery plus postoperative radiotherapy with breast-conserving surgery alone, and all have shown an increased risk of local recurrence if radiotherapy is omitted but no difference in survival. One of the largest of these trials, the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-06 study, . . .</description><subject>Age Factors</subject><subject>Aged</subject><subject>Antineoplastic Agents, Hormonal - therapeutic use</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - radiotherapy</subject><subject>Breast Neoplasms - therapy</subject><subject>Combined Modality Therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Mastectomy</subject><subject>Mastectomy, Segmental</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local</subject><subject>Neoplasms, Hormone-Dependent - therapy</subject><subject>Tamoxifen - therapeutic use</subject><subject>Therapy</subject><subject>Tumors</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpt0F1LwzAUBuAgipvTK--lKHgj1aSnTZPLOeYXc4LodUnTU93ol0mL9M4f4S_0l5ixgSLmJoE8vJzzEnLI6DmjEb-YT-_ukYaCxbBFhiwC8MOQ8m0ypDQQfhhLGJA9a5fUHRbKXTJwKAwEY0MyuTSobOs9qmxRt69oVNN7Km_ReLOubFC3ddl7Xx-f3rz2ZnX14j7GxbvqrTdHjdYq0--TnVwVFg8294g8X02fJjf-7OH6djKe-Rpi2fqCCSlzkKmbLoMAORMQKCFAaPfOZK7SGCINPA450DTVAWdcC8VZlAaIAkbkdJ3bmPqtQ9sm5cJqLApVYd3ZhHMBMpKRg8d_4LLuTOVmS4IAJEAYr9DZGmlTW2swTxqzKN06CaPJqtjkV7FOH20iu7TE7MdumnTgZA3K0iYVLst_Y74B9jd8dA</recordid><startdate>20040902</startdate><enddate>20040902</enddate><creator>Smith, Ian E</creator><creator>Ross, Gillian M</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20040902</creationdate><title>Breast Radiotherapy after Lumpectomy — No Longer Always Necessary</title><author>Smith, Ian E ; Ross, Gillian M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c379t-81899f39b440d32e61832a8838ce61d9fab735c3674630bbc2616c8a615b2ee83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Age Factors</topic><topic>Aged</topic><topic>Antineoplastic Agents, Hormonal - therapeutic use</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - radiotherapy</topic><topic>Breast Neoplasms - therapy</topic><topic>Combined Modality Therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Mastectomy</topic><topic>Mastectomy, Segmental</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local</topic><topic>Neoplasms, Hormone-Dependent - therapy</topic><topic>Tamoxifen - therapeutic use</topic><topic>Therapy</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Smith, Ian E</creatorcontrib><creatorcontrib>Ross, Gillian M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database (ProQuest)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Smith, Ian E</au><au>Ross, Gillian M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Breast Radiotherapy after Lumpectomy — No Longer Always Necessary</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2004-09-02</date><risdate>2004</risdate><volume>351</volume><issue>10</issue><spage>1021</spage><epage>1023</epage><pages>1021-1023</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><coden>NEJMAG</coden><abstract>Breast-conserving surgery followed by radiotherapy is the standard of care for women with small breast cancers who wish to avoid mastectomy. This approach achieves good local control, does not disturb the women's body image or impair survival,
1
and has been an important step forward in the management of this disease.
Several trials have compared breast-conserving surgery plus postoperative radiotherapy with breast-conserving surgery alone, and all have shown an increased risk of local recurrence if radiotherapy is omitted but no difference in survival. One of the largest of these trials, the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-06 study, . . .</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>15342811</pmid><doi>10.1056/NEJMe048173</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-4793 |
ispartof | The New England journal of medicine, 2004-09, Vol.351 (10), p.1021-1023 |
issn | 0028-4793 1533-4406 |
language | eng |
recordid | cdi_proquest_miscellaneous_66839595 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; ProQuest Central UK/Ireland; New England Journal of Medicine |
subjects | Age Factors Aged Antineoplastic Agents, Hormonal - therapeutic use Breast cancer Breast Neoplasms - radiotherapy Breast Neoplasms - therapy Combined Modality Therapy Female Humans Mastectomy Mastectomy, Segmental Middle Aged Neoplasm Recurrence, Local Neoplasms, Hormone-Dependent - therapy Tamoxifen - therapeutic use Therapy Tumors |
title | Breast Radiotherapy after Lumpectomy — No Longer Always Necessary |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T04%3A21%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Breast%20Radiotherapy%20after%20Lumpectomy%20%E2%80%94%20No%20Longer%20Always%20Necessary&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Smith,%20Ian%20E&rft.date=2004-09-02&rft.volume=351&rft.issue=10&rft.spage=1021&rft.epage=1023&rft.pages=1021-1023&rft.issn=0028-4793&rft.eissn=1533-4406&rft.coden=NEJMAG&rft_id=info:doi/10.1056/NEJMe048173&rft_dat=%3Cproquest_cross%3E66839595%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223933475&rft_id=info:pmid/15342811&rfr_iscdi=true |